256 related articles for article (PubMed ID: 6465016)
21. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
[TBL] [Abstract][Full Text] [Related]
22. Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia.
Morady F; Scheinman MM; Shen E; Shapiro W; Sung RJ; DiCarlo L
Am J Cardiol; 1983 Jan; 51(1):156-9. PubMed ID: 6401373
[TBL] [Abstract][Full Text] [Related]
23. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
Kim SG; Felder SD; Figura I; Johnston DR; Mercando AD; Fisher JD
Am J Cardiol; 1987 Jun; 59(15):1314-8. PubMed ID: 3591686
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
Munsif AN; Saksena S
Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia.
Klein RC; Machell C; Rushforth N; Standefur J
Am Heart J; 1988 Jan; 115(1 Pt 1):96-101. PubMed ID: 3336990
[TBL] [Abstract][Full Text] [Related]
28. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
[TBL] [Abstract][Full Text] [Related]
32. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic testing: predictive of amiodarone efficacy in recurrent sustained ventricular tachycardia?
Mas IJ; Massumi A; Harlan M; Seger JJ; Hall RJ
Tex Heart Inst J; 1987 Dec; 14(4):382-8. PubMed ID: 15227294
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
35. Amiodarone: correlation of early and late electrophysiologic studies with outcome.
Kadish AH; Marchlinski FE; Josephson ME; Buxton AE
Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759
[TBL] [Abstract][Full Text] [Related]
36. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
37. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
Rothbart ST; Saksena S
Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
[TBL] [Abstract][Full Text] [Related]
38. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
Capparelli EV; Kluger J; Regnier JC; Chow MS
J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
[TBL] [Abstract][Full Text] [Related]
39. Beneficial effect of amiodarone on pacing induced terminability of reentrant ventricular tachycardia.
Chinushi M; Uchiyama H; Nakagawa I; Washizuka T; Aizawa Y
Jpn Heart J; 1999 Jul; 40(4):471-5. PubMed ID: 10611912
[TBL] [Abstract][Full Text] [Related]
40. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
